Home - Products - Others - Other Targets - Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside

Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside

CAS No. 142451-65-8

Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside( —— )

Catalog No. M23575 CAS No. 142451-65-8

Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 86 In Stock
2MG 188 In Stock
5MG 325 In Stock
10MG 440 In Stock
25MG 644 In Stock
50MG 854 In Stock
100MG 1144 In Stock
200MG 1553 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine.
  • Description
    Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside is a natural peoduct isolated from Arabian jasmine
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    142451-65-8
  • Formula Weight
    594.52
  • Molecular Formula
    C27H30O15
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC2=C(OC3=CC(=CC(=C3C2=O)O)O)C4=CC=C(C=C4)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ganoderic acid GS-1

    Ganoderic acid GS-1, a highly oxygenated lanostane-type triterpenoid, has anti-HIV-1 protease activities with an IC 50 of 58 μM.

  • Sisomicin Sulfate

    Sisomicin sulfate is an aminoglycoside antibiotic.

  • Iodoantipyrine

    Iodoantipyrine is a commonly-used indicator and is used to evaluate in rats by measuring torcular venous efflux after systemic injection of the indicator under conditions of normal and high CBF.